Safinamide

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 347 publications

Marked Improvement of Sialorrhea with Safinamide in Parkinson's Disease: A Case Series.

Marked Improvement of Sialorrhea with Safinamide in Parkinson's Disease: A Case Series.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: April 24, 2026

Combination therapy of levodopa with safinamide is more effective than with rasagiline and zonisamide in Asian Parkinson's disease patients with motor fluctuations: a systematic review and network meta-analysis of randomized controlled trials.

Combination therapy of levodopa with safinamide is more effective than with rasagiline and zonisamide in Asian Parkinson's disease patients with motor fluctuations: a systematic review and network meta-analysis of randomized controlled trials.

Journal: Journal of neurology

Published: March 23, 2026

A dual timeline of safinamide effects in Parkinson's disease: mechanistic rationale and clinical implications.

A dual timeline of safinamide effects in Parkinson's disease: mechanistic rationale and clinical implications.

Journal: Frontiers in neurology

Published: March 12, 2026

Advanced Parkinson's disease treatment patterns in Italy: results from a multicenter observational study.

Advanced Parkinson's disease treatment patterns in Italy: results from a multicenter observational study.

Journal: Annals of medicine

Published: March 05, 2026

In Vivo Electrochemical Monitoring of Safinamide Pharmacokinetics in the Brain Explores Its Correlation With Vision-Related Neuronal Activity.

In Vivo Electrochemical Monitoring of Safinamide Pharmacokinetics in the Brain Explores Its Correlation With Vision-Related Neuronal Activity.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 29, 2026

Diplopia possibly induced by safinamide in parkinson's disease.

Diplopia possibly induced by safinamide in parkinson's disease.

Journal: Acta neurologica Belgica

Published: January 26, 2026

Development of 1-(substituted benzofuran-2-yl)-3-(halogen-substituted phenyl)prop-2-en-1-ones as potent, reversible, and selective MAO-B inhibitors for Parkinson's Disease.

Development of 1-(substituted benzofuran-2-yl)-3-(halogen-substituted phenyl)prop-2-en-1-ones as potent, reversible, and selective MAO-B inhibitors for Parkinson's Disease.

Journal: Scientific reports

Published: January 24, 2026

Treatment stability comparison among different ADD-ON therapies in fluctuating Parkinson's disease patients: the role of clinical and demographic factors.

Treatment stability comparison among different ADD-ON therapies in fluctuating Parkinson's disease patients: the role of clinical and demographic factors.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: December 15, 2025

Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.

Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.

Journal: Drugs

Published: November 26, 2025

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis.

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis.

Journal: Frontiers in neurology

Published: November 24, 2025

A computational-based search of natural product derived multi-target ligands for the management of Alzheimer's and Parkinson's disease using structure-based pharmacophore modelling, virtual screening, MD docking, free energy analysis, ADMET profiling and DFT studies.

A computational-based search of natural product derived multi-target ligands for the management of Alzheimer's and Parkinson's disease using structure-based pharmacophore modelling, virtual screening, MD docking, free energy analysis, ADMET profiling and DFT studies.

Journal: SAR and QSAR in environmental research

Published: November 19, 2025

Treatment strategies for motor fluctuations in Parkinson's disease: a systematic review of efficacy, functionality, and drug accessibility with a focus on Latin America.

Treatment strategies for motor fluctuations in Parkinson's disease: a systematic review of efficacy, functionality, and drug accessibility with a focus on Latin America.

Journal: Frontiers in pharmacology

Published: October 14, 2025

Showing 1-12 of 347

Last Updated: 06/30/2026